Most pet insurance companies allow pet parents to enroll their kittens as early as six to eight weeks old. Enrolling your ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that company management will participate in two upcoming ...

But if not, you'll need to find stocks that hold the potential to pack more punch. The past doesn't predict the future, but ...

of the Polycystic Kidney Disease Foundation said that rare disease patients are closely following the advances in basic research and “patients are impatiently waiting for treatments”.

Vertex Pharmaceuticals Incorporated today announced management participation in three upcoming investor conferences. Stuart Arbuckle, Executive Vice President and Chief Operating Officer, and David ...

From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...

Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

Researchers developed a new gene-editing strategy that dramatically boosts the effectiveness of gene therapies in the liver, a breakthrough that could lead to new treatments for about 700 genetic ...